Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1Gastrointestinal 1

Conditions

Head and Neck Neoplasms 330Nasopharyngeal Carcinoma 223Squamous Cell Carcinoma of Head and Neck 205Thyroid Neoplasms 123Mouth Neoplasms 70Nasopharyngeal Neoplasms 55Thyroid Nodule 52Oropharyngeal Neoplasms 42Laryngeal Neoplasms 42Breast Neoplasms 42Neoplasms 33Neoplasm Metastasis 29Thyroid Cancer, Papillary 28Lung Neoplasms 27Hypopharyngeal Neoplasms 27Colorectal Neoplasms 26Carcinoma, Non-Small-Cell Lung 25Esophageal Neoplasms 23Recurrence 22Pancreatic Neoplasms 22Stomach Neoplasms 21Carcinoma, Squamous Cell 21Thyroid Diseases 20Prostatic Neoplasms 19Stomatitis 18Ovarian Neoplasms 18Salivary Gland Neoplasms 17Melanoma 17Uterine Cervical Neoplasms 15Radiation Injuries 15

Interventions

golotimod 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gastroenteritis × Head & Neck × Clear all
NCT01247246 2014-05-26

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

SciClone Pharmaceuticals

Phase 2 Unknown
160 enrolled
GastrointestinalHead & NeckOther

Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, Head and Neck Neoplasms, Stomatognathic Diseases, Mouth Diseases, Neoplasms, Neoplasms by Site, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡